Nasdaq (Nasdaq: NDAQ) announced today the results of the semi-annual review of the OMX Stockholm Benchmark™ Index, (Nasdaq Stockholm: OMXSB), which will become effective at market open on Monday, December 2, 2024.
The following securities will be added to the lndex: Alleima AB (ALLEI), Beijer Ref AB ser. B (BEIJ B), Betsson AB ser. B (BETS B), Bravida Holding AB (BRAV), Clas Ohlson AB ser. B (CLAS B), MEKO AB (MEKO), NP3 Fastigheter AB (NP3), Securitas AB ser. B (SECU B) and Xvivo Perfusion AB (XVIVO).
The OMX Stockholm Benchmark™ Index measures the performance of a selection of the largest and most traded securities listed on Nasdaq Stockholm AB. The Index is reviewed semi-annually in June and December.
As a result of the semi-annual review, the following securities will be removed from the Index: AFRY AB (AFRY), Biotage AB (BIOT), Kinnevik AB ser. B (KINV B), Solid Försäkringsaktiebolag (SFAB), SSAB AB ser. A (SSAB A), Millicom International Cellular S.A. SDB (TIGO SDB), and VBG GROUP AB ser. B (VBG B).
For a list of current Index Securities please refer to Nasdaq's Global Index Watch.
For more information, please refer to the OMX Stockholm Benchmark Index Methodology.
